| In December 2019,a number of viral pneumonia cases were found in Wuhan,China.In January 2020,the World Health Organization(WHO)announced that the outbreak of COVID-19 has constituted a global "pandemic",and the novel coronavirus epidemic has become an international public health emergency(PHEIC).In the face of the impact of COVID-19,the world economy has obviously declined,international trade has been hit hard,and the international market is full of many challenges.Novel coronavirus mainly attacks human lungs,and timely oxygen therapy to maintain blood oxygen in the normal range and ensure the normal operation of the patient’s lung function are the most important.Therefore,endotracheal intubation is the most reliable method to maintain smooth breathing.Intubation has become an extremely important link in the treatment of COVID-19.GK Pharm is a company focusing on the R & D,production and sales of muscle relaxant APIs.Through the analysis of the international and domestic industry background of AB API,the macro environment and current market segmentation,objectives and positioning of GK Pharm are analyzed in details by using the PEST analysis method and STP theory.Taking GK Pharm as the research object,this paper studies the situation of the company in the post epidemic era,and analyzes its marketing status and marketing problems.Using the marketing mix strategy,improve and enhance the South American market share,stabilize the current market and expand more South American markets,design targeted marketing strategy improvement for GK Pharm,establish a brand strategy system,analyze various internal and external guarantees it should provide for the South American Marketing improvement strategy,analyze and optimize the corresponding marketing strategy,and finally obtain a marketing optimization strategy that is more suitable for GK Pharm.Through the optimization of marketing strategy and the listed strategy implementation guarantee research on AB API of GK Pharm,this paper not only puts forward substantive marketing suggestions for GK Pharm,but also hopes to inspire other companies engaged in pharmaceutical API in China,familiarize themselves with the market environment in South America,expand the market share in South America,and promote the further development of China’s pharmaceutical industry’s export. |